Table of Content

1 SGLT2 Inhibitor Market Overview
1.1 Product Overview and Scope of SGLT2 Inhibitor
1.2 SGLT2 Inhibitor Segment by Type
1.2.1 Global SGLT2 Inhibitor Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Dapagliflozin
1.2.3 Canagliflozin
1.2.4 Empagliflozin
1.2.5 Other
1.3 SGLT2 Inhibitor Segment by Application
1.3.1 SGLT2 Inhibitor Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.4 Global SGLT2 Inhibitor Market Size Estimates and Forecasts
1.4.1 Global SGLT2 Inhibitor Revenue 2016-2027
1.4.2 Global SGLT2 Inhibitor Sales 2016-2027
1.4.3 SGLT2 Inhibitor Market Size by Region: 2016 Versus 2021 Versus 2027

2 SGLT2 Inhibitor Market Competition by Manufacturers
2.1 Global SGLT2 Inhibitor Sales Market Share by Manufacturers (2016-2021)
2.2 Global SGLT2 Inhibitor Revenue Market Share by Manufacturers (2016-2021)
2.3 Global SGLT2 Inhibitor Average Price by Manufacturers (2016-2021)
2.4 Manufacturers SGLT2 Inhibitor Manufacturing Sites, Area Served, Product Type
2.5 SGLT2 Inhibitor Market Competitive Situation and Trends
2.5.1 SGLT2 Inhibitor Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest SGLT2 Inhibitor Players Market Share by Revenue
2.5.3 Global SGLT2 Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 SGLT2 Inhibitor Retrospective Market Scenario by Region
3.1 Global SGLT2 Inhibitor Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global SGLT2 Inhibitor Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America SGLT2 Inhibitor Market Facts & Figures by Country
3.3.1 North America SGLT2 Inhibitor Sales by Country
3.3.2 North America SGLT2 Inhibitor Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe SGLT2 Inhibitor Market Facts & Figures by Country
3.4.1 Europe SGLT2 Inhibitor Sales by Country
3.4.2 Europe SGLT2 Inhibitor Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific SGLT2 Inhibitor Market Facts & Figures by Region
3.5.1 Asia Pacific SGLT2 Inhibitor Sales by Region
3.5.2 Asia Pacific SGLT2 Inhibitor Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America SGLT2 Inhibitor Market Facts & Figures by Country
3.6.1 Latin America SGLT2 Inhibitor Sales by Country
3.6.2 Latin America SGLT2 Inhibitor Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa SGLT2 Inhibitor Market Facts & Figures by Country
3.7.1 Middle East and Africa SGLT2 Inhibitor Sales by Country
3.7.2 Middle East and Africa SGLT2 Inhibitor Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global SGLT2 Inhibitor Historic Market Analysis by Type
4.1 Global SGLT2 Inhibitor Sales Market Share by Type (2016-2021)
4.2 Global SGLT2 Inhibitor Revenue Market Share by Type (2016-2021)
4.3 Global SGLT2 Inhibitor Price by Type (2016-2021)

5 Global SGLT2 Inhibitor Historic Market Analysis by Application
5.1 Global SGLT2 Inhibitor Sales Market Share by Application (2016-2021)
5.2 Global SGLT2 Inhibitor Revenue Market Share by Application (2016-2021)
5.3 Global SGLT2 Inhibitor Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly SGLT2 Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Eli Lilly Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim SGLT2 Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Boehringer Ingelheim Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson SGLT2 Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Johnson & Johnson Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca SGLT2 Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.4.4 AstraZeneca Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck SGLT2 Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Merck Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer SGLT2 Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Pfizer Product Portfolio
6.6.5 Pfizer Recent Developments/Updates

7 SGLT2 Inhibitor Manufacturing Cost Analysis
7.1 SGLT2 Inhibitor Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of SGLT2 Inhibitor
7.4 SGLT2 Inhibitor Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 SGLT2 Inhibitor Distributors List
8.3 SGLT2 Inhibitor Customers

9 SGLT2 Inhibitor Market Dynamics
9.1 SGLT2 Inhibitor Industry Trends
9.2 SGLT2 Inhibitor Growth Drivers
9.3 SGLT2 Inhibitor Market Challenges
9.4 SGLT2 Inhibitor Market Restraints

10 Global Market Forecast
10.1 SGLT2 Inhibitor Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of SGLT2 Inhibitor by Type (2022-2027)
10.1.2 Global Forecasted Revenue of SGLT2 Inhibitor by Type (2022-2027)
10.2 SGLT2 Inhibitor Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of SGLT2 Inhibitor by Application (2022-2027)
10.2.2 Global Forecasted Revenue of SGLT2 Inhibitor by Application (2022-2027)
10.3 SGLT2 Inhibitor Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of SGLT2 Inhibitor by Region (2022-2027)
10.3.2 Global Forecasted Revenue of SGLT2 Inhibitor by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global SGLT2 Inhibitor Sales (Kg) Growth Rate Comparison by Type (2021-2027)
Table 2. Global SGLT2 Inhibitor Sales (Kg) Comparison by Application (2021-2027)
Table 3. Global SGLT2 Inhibitor Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers SGLT2 Inhibitor Covered in This Study
Table 5. Global SGLT2 Inhibitor Sales (Kg) of Key Manufacturers (2016-2021)
Table 6. Global SGLT2 Inhibitor Sales Share by Manufacturers (2016-2021)
Table 7. Global SGLT2 Inhibitor Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global SGLT2 Inhibitor Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market SGLT2 Inhibitor Average Price (USD/g) of Key Manufacturers (2016-2021)
Table 10. Manufacturers SGLT2 Inhibitor Manufacturing Sites and Area Served
Table 11. Manufacturers SGLT2 Inhibitor Product Type
Table 12. Global SGLT2 Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global SGLT2 Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in SGLT2 Inhibitor as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global SGLT2 Inhibitor Sales by Region (2016-2021) & (Kg)
Table 16. Global SGLT2 Inhibitor Sales Market Share by Region (2016-2021)
Table 17. Global SGLT2 Inhibitor Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America SGLT2 Inhibitor Sales by Country (2016-2021) & (Kg)
Table 19. North America SGLT2 Inhibitor Sales Market Share by Country (2016-2021)
Table 20. North America SGLT2 Inhibitor Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America SGLT2 Inhibitor Revenue Market Share by Country (2016-2021)
Table 22. Europe SGLT2 Inhibitor Sales by Country (2016-2021) & (Kg)
Table 23. Europe SGLT2 Inhibitor Sales Market Share by Country (2016-2021)
Table 24. Europe SGLT2 Inhibitor Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe SGLT2 Inhibitor Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific SGLT2 Inhibitor Sales by Region (2016-2021) & (Kg)
Table 27. Asia Pacific SGLT2 Inhibitor Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific SGLT2 Inhibitor Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific SGLT2 Inhibitor Revenue Market Share by Region (2016-2021)
Table 30. Latin America SGLT2 Inhibitor Sales by Country (2016-2021) & (Kg)
Table 31. Latin America SGLT2 Inhibitor Sales Market Share by Country (2016-2021)
Table 32. Latin America SGLT2 Inhibitor Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America SGLT2 Inhibitor Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa SGLT2 Inhibitor Sales by Country (2016-2021) & (Kg)
Table 35. Middle East and Africa SGLT2 Inhibitor Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa SGLT2 Inhibitor Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa SGLT2 Inhibitor Revenue Market Share by Country (2016-2021)
Table 38. Global SGLT2 Inhibitor Sales (Kg) by Type (2016-2021)
Table 39. Global SGLT2 Inhibitor Sales Market Share by Type (2016-2021)
Table 40. Global SGLT2 Inhibitor Revenue (Million US$) by Type (2016-2021)
Table 41. Global SGLT2 Inhibitor Revenue Share by Type (2016-2021)
Table 42. Global SGLT2 Inhibitor Price (USD/g) by Type (2016-2021)
Table 43. Global SGLT2 Inhibitor Sales (Kg) by Application (2016-2021)
Table 44. Global SGLT2 Inhibitor Sales Market Share by Application (2016-2021)
Table 45. Global SGLT2 Inhibitor Revenue (Million US$) by Application (2016-2021)
Table 46. Global SGLT2 Inhibitor Revenue Share by Application (2016-2021)
Table 47. Global SGLT2 Inhibitor Price (USD/g) by Application (2016-2021)
Table 48. Eli Lilly Corporation Information
Table 49. Eli Lilly Description and Business Overview
Table 50. Eli Lilly SGLT2 Inhibitor Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 51. Eli Lilly SGLT2 Inhibitor Product
Table 52. Eli Lilly Recent Developments/Updates
Table 53. Boehringer Ingelheim Corporation Information
Table 54. Boehringer Ingelheim Description and Business Overview
Table 55. Boehringer Ingelheim SGLT2 Inhibitor Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 56. Boehringer Ingelheim SGLT2 Inhibitor Product
Table 57. Boehringer Ingelheim Recent Developments/Updates
Table 58. Johnson & Johnson Corporation Information
Table 59. Johnson & Johnson Description and Business Overview
Table 60. Johnson & Johnson SGLT2 Inhibitor Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 61. Johnson & Johnson SGLT2 Inhibitor Product
Table 62. Johnson & Johnson Recent Developments/Updates
Table 63. AstraZeneca Corporation Information
Table 64. AstraZeneca Description and Business Overview
Table 65. AstraZeneca SGLT2 Inhibitor Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 66. AstraZeneca SGLT2 Inhibitor Product
Table 67. AstraZeneca Recent Developments/Updates
Table 68. Merck Corporation Information
Table 69. Merck Description and Business Overview
Table 70. Merck SGLT2 Inhibitor Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 71. Merck SGLT2 Inhibitor Product
Table 72. Merck Recent Developments/Updates
Table 73. Pfizer Corporation Information
Table 74. Pfizer Description and Business Overview
Table 75. Pfizer SGLT2 Inhibitor Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 76. Pfizer SGLT2 Inhibitor Product
Table 77. Pfizer Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. SGLT2 Inhibitor Distributors List
Table 81. SGLT2 Inhibitor Customers List
Table 82. SGLT2 Inhibitor Market Trends
Table 83. SGLT2 Inhibitor Growth Drivers
Table 84. SGLT2 Inhibitor Market Restraints
Table 85. Global SGLT2 Inhibitor Sales Forecast by Type (2022-2027) & (Kg)
Table 86. Global SGLT2 Inhibitor Sales Market Share Forecast by Type (2022-2027)
Table 87. Global SGLT2 Inhibitor Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 88. Global SGLT2 Inhibitor Revenue Market Share Forecast by Type (2022-2027)
Table 89. Global SGLT2 Inhibitor Sales Forecast by Application (2022-2027) & (Kg)
Table 90. Global SGLT2 Inhibitor Sales Market Share Forecast by Application (2022-2027)
Table 91. Global SGLT2 Inhibitor Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 92. Global SGLT2 Inhibitor Revenue Market Share Forecast by Application (2022-2027)
Table 93. Global SGLT2 Inhibitor Sales Forecast by Region (2022-2027) & (Kg)
Table 94. Global SGLT2 Inhibitor Sales Market Share Forecast by Region (2022-2027)
Table 95. Global SGLT2 Inhibitor Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 96. Global SGLT2 Inhibitor Revenue Market Share Forecast by Region (2022-2027)
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of SGLT2 Inhibitor
Figure 2. Global SGLT2 Inhibitor Market Share by Type in 2020 & 2027
Figure 3. Dapagliflozin Product Picture
Figure 4. Canagliflozin Product Picture
Figure 5. Empagliflozin Product Picture
Figure 6. Other Product Picture
Figure 7. Global SGLT2 Inhibitor Market Share by Application in 2020 & 2027
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Global SGLT2 Inhibitor Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global SGLT2 Inhibitor Market Size 2016-2027 (US$ Million)
Figure 12. Global SGLT2 Inhibitor Sales 2016-2027 (Kg)
Figure 13. Global SGLT2 Inhibitor Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. SGLT2 Inhibitor Sales Share by Manufacturers in 2020
Figure 15. Global SGLT2 Inhibitor Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest SGLT2 Inhibitor Players: Market Share by Revenue in 2020
Figure 17. SGLT2 Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global SGLT2 Inhibitor Sales Market Share by Region (2016-2021)
Figure 19. Global SGLT2 Inhibitor Sales Market Share by Region in 2020
Figure 20. Global SGLT2 Inhibitor Revenue Market Share by Region (2016-2021)
Figure 21. Global SGLT2 Inhibitor Revenue Market Share by Region in 2020
Figure 22. U.S. SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E SGLT2 Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of SGLT2 Inhibitor by Type (2016-2021)
Figure 47. Sales Market Share of SGLT2 Inhibitor by Application (2016-2021)
Figure 48. Sales Market Share of SGLT2 Inhibitor by Application in 2020
Figure 49. Revenue Share of SGLT2 Inhibitor by Application (2016-2021)
Figure 50. Revenue Share of SGLT2 Inhibitor by Application in 2020
Figure 51. Manufacturing Cost Structure of SGLT2 Inhibitor
Figure 52. Manufacturing Process Analysis of SGLT2 Inhibitor
Figure 53. SGLT2 Inhibitor Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed